Analyzing Stock On Your Own: Mesoblast Ltd ADR (NASDAQ: MESO)

Mesoblast Ltd ADR (NASDAQ:MESO) does about 2.20M shares in volume on a normal day but saw 1776042 shares change hands in Monday trading. The company now has a market cap of 717.06M USD. Its current market price is $6.29, marking an increase of 8.45% compared to the previous close of $5.80. The 52 week high reached by this stock is $10.24 whilst the lowest price level in 52 weeks is $1.61.

Mesoblast Ltd ADR (MESO) has a 20-day trading average at $3.78 and the current price is -38.57% off the 52-week high compared with 290.68% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.68 and its 200-day simple moving average is $3.46. If we look at the stock’s price movements over the week, volatility stands at 11.83%, which increases to 14.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 76.28 to suggest the stock is overbought.

The consensus objective for the share price is $8.87, suggesting that the stock has a potential upside of 29.09% over the period.

Mesoblast Ltd ADR (MESO) stock is up 3.45% over the week and 185.91% over the past month. Its price is 185.91% year-to-date and 1.78% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/29/2023, with the company’s earnings per share (EPS) of -$0.28 above consensus estimates by $0.03. MESO’s earnings per share are forecast to grow by 35.10% this year and -8.30% over next year.

To reach the target analysts have set, the stock logically needs to grow 29.09 percent from here.

Outstanding shares total 85.82M with insiders holding 0.00% of the shares and institutional holders owning 0.73% of the company’s common stock. The company has a return on investment of -13.22% and return on equity of -16.40%. The beta has a value of 3.58. Price to book ratio is 1.25 and price to sales ratio is 93.00.